Reply to: 'Why do obese patients with heart failure with reduced ejection fraction have better outcomes from pharmacological treatments?'

Eur J Heart Fail. 2023 Jun;25(6):922-923. doi: 10.1002/ejhf.2880. Epub 2023 May 8.

Authors

Chiara Cappelletto^{1

2}, Davide Stolfo^{1

2}, Gianluigi Savarese^{1

3}

Affiliations

¹ Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
² Division of Cardiology, Cardiothoracovascular Department, Cattinara Hospital, Azienda Sanitaria Universitaria Giuliano Isontina and University of Trieste, Trieste, Italy.
³ Heart and Vascular and Neuro Theme, Karolinska University Hospital, Stockholm, Sweden.

PMID: 37114368
DOI: 10.1002/ejhf.2880

No abstract available

Publication types

Letter
Comment

MeSH terms

Heart Failure* / complications
Heart Failure* / drug therapy
Humans
Obesity / complications
Stroke Volume
Ventricular Dysfunction, Left*
Ventricular Function, Left